Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rapsyn mutations in 16 unrelated patients with a congenital/hereditary myasthenic syndrome were identified, and a mutation (N88K) common to each of them was found. Two distinct phenotypes were noted: early and late onset. The former is frequently associated with arthrogryposis multiplex congenita and life-threatening crises. The late-onset phenotype developed in adolescence or adulthood and was initially mistaken for seronegative myasthenia gravis. Recognition of this late-onset phenotype should prevent inappropriate immunotherapy.


Journal article



Publication Date





826 - 828


Adolescent, Adult, Age of Onset, Amino Acid Substitution, Arthrogryposis, Asia, Child, Child, Preschool, Codon, Consanguinity, DNA Mutational Analysis, Europe, Female, Genotype, Humans, Male, Muscle Proteins, Mutation, Missense, Myasthenia Gravis, Myasthenic Syndromes, Congenital, Phenotype, Point Mutation